knowledge -WSS

knowledge

author：knowledge 2025-09-28 23:48:04 - browse：3

The FDA building -- First Opinion coverage from STAT — Adobe

The clearance of a first-of-its-kind cancer treatment made by Amgen is on shakier ground following a Food and Drug Administration advisory committee meeting Thursday.

Regulatory advisers voted 10-2 that the data on the company’s drug Lumakras, a treatment for lung cancer, could not be properly assessed. Lumakras targets a specific mutation to a protein called KRAS, which is one of the most common genetic mutations in cancer.

The vote comes as Amgen is hoping to convert a conditional approval for the drug to a full approval based on a 345-person study called CodeBreaK 200, in which Lumakras met the primary endpoint, delaying tumor growth approximately five weeks longer than the standard of care medication, docetaxel. The drug didn’t extend patients’ overall survival.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Microsoft strikes partnership with Duke Health to advance health AI

entertainment

WSS

Liz Cheney makes 1st public comment since Trump's election interference indictments

The pain doctors face in trying to build their families

Evacuations in place as 3 wildfires burn in eastern Washington state

Liz Cheney makes 1st public comment since Trump's election interference indictments

Baltimore teen accused of firing into crowd during block party mass shooting

Liz Cheney makes 1st public comment since Trump's election interference indictments

explore

knowledge

hotspot

What does generative AI mean for health care? We asked experts

'Ancient DNA,' 23andMe reveal African American ancestries

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Verily hires former Apple Health leader as chief scientific officer

At least 13 dead in Texas as scorching temps continue

TytoCare raises $49 million to build out AI

United colonoscopy coverage change 'may cost lives,' doctors say

Eye stem cell transplant could help restore vision in injured people

As demand for Covid shots wanes, Moderna seeks its next success

OTC birth control: A brief history of over the counter pill design

explore

Lung cancer is America's deadliest cancer. Yet so few get screened

2 US Navy sailors arrested for allegedly spying for China

OTC birth control: A brief history of over the counter pill design

For BCIs, commercial hurdles may be bigger than scientific ones

Lung cancer is America's deadliest cancer. Yet so few get screened

FDA approves first treatment for ultra

hotspot

entertainment

knowledge

explore